Vision Point Advisory Group, LLC Danaher Corp Transaction History

Vision Point Advisory Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$235.51 - $267.98 $5,652 - $6,431	-24 Reduced 6.78%	330 $82,000
Q1 2024 May 10, 2024	SELL	$224.58 - $256.19 $87,810 - $100,170	-391 Reduced 52.48%	354 $88,000
Q4 2023 Feb 07, 2024	SELL	$185.1 - $233.13 $26,469 - $33,337	-143 Reduced 16.1%	745 $172,000
Q3 2023 Dec 06, 2023	SELL	$233.08 - $265.59 $39,623 - $45,150	-170 Reduced 16.07%	888 $220,000
Q2 2023 Aug 21, 2023	BUY	$224.99 - $256.14 $24,073 - $27,406	107 Added 11.25%	1,058 $253,000
Q1 2023 May 15, 2023	SELL	$239.75 - $277.0 $13,905 - $16,066	-58 Reduced 5.75%	951 $239,000
Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $67,114 - $78,476	-278 Reduced 21.6%	1,009 $267,000
Q3 2022 Nov 17, 2022	BUY	$247.06 - $1507.4 $18,529 - $113,055	75 Added 6.19%	1,287 $332,000
Q2 2022 Aug 12, 2022	BUY	$237.11 - $299.66 $287,377 - $363,187	1,212 New	1,212 $353,000

2,432

563M

3.94M

4.11M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Vision Point Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Vision Point Advisory Group, LLC with notifications on news.